Hongrui Niu

The Second People’s Hospital of Lianyungang

SCHOLARLY PAPERS

1

DOWNLOADS

72

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

An Open-Label, Randomized Phase III Study of Telpegfilgrastim in Preventing Chemotherapy-Induced Neutropenia in Patients with Non-Small Cell Lung Cancer

Number of pages: 30 Posted: 12 Jun 2024
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Henan University of Science and Technology - Department of Medical Oncology, Zhengzhou University - Affiliated Luoyang Central Hospital, Gannan Medical University - First Affiliated Hospital, Shaanxi Provincial Cancer Hospital, Hubei University of Arts and Science - Department of Oncology, Zhengzhou First People’s Hospital, Henan University of Science and Technology - Department of Medical Oncology, Luohe Central Hospital, Luohe Central Hospital, Harbin Medical University - Cancer Hospital, Xuzhou Medical University - Affiliated Hospital, Fujian Medical University - Zhangzhou Affiliated Hospital, Zhengzhou University - The Affiliated Cancer Hospital, Xinxiang Medical University - First Affiliated Hospital, The Second People’s Hospital of Lianyungang, The Second People’s Hospital of Lianyungang, Lianyungang First People's Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs and Xiamen Amoytop Biotech Co., LTD
Downloads 72 (703,074)

Abstract:

Loading...

Recombinant human granulocyte colony stimulating factor, filgrastim, pegfilgrastim, neutropenia, lung cancer, NSCLC